

Related Companies | [] | ||||||||
Related Funds | [] | ||||||||
English | |||||||||
oda_MaterialEventDisclosureGeneralAbstract| |
| ||||||||
oda_UpdateAnnouncementFlag| |
| Hayır (No) | |||||||
oda_CorrectionAnnouncementFlag| |
| Hayır (No) | |||||||
oda_DateOfThePreviousNotificationAboutTheSameSubject| |
| - | |||||||
oda_DelayedAnnouncementFlag| |
| Hayır (No) | |||||||
oda_AnnouncementContentSection| |
| ||||||||
oda_ExplanationSection| |
| ||||||||
oda_ExplanationTextBlock| | As Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.Ş., we are pleased to present to our investors the key developments in our operational performance and profitability indicators based on our financial results for the first half of 2026. In the first half of 2026:
These financial results demonstrate a significant improvement in our Company's profitability structure and operational efficiency. In particular, the strong growth in gross profit and operating profit, together with the improvement in profit margns, indicates that our core operations are developing in a more efficient manner and generating higher value added. The results achieved in the first half of 2026 demonstrate not only our Company's growth performance, but also the progress we have made in improving the quality of our growth and strengthening our profitability capacity. The improvements in operational efficiency and cost management provide a strong foundation for further strengthening sustainable financial performance in the coming periods. Our Company continues to pursue its efforts with determination to expand its value-added product and service portfolio, increase production capacity, capitalize on opportunities in domestic and international markets, and strengthen its long-term revenue generation potential. In this regard, supported by our existing operational infrastructure, the products and services currently under development, and new business opportunities, we aim to further strengthen our Company's sustainable growth and profitability capacity. This disclosure is also made in Turkish, and in case of any discrepancy between the disclosure texts, the Turkish disclosure shall prevail. | ||||||||
We proclaim that our above disclosure is in conformity with the principles set down in “Material Events Communiqué” of Capital Markets Board, and it fully reflects all information coming to our knowledge on the subject matter thereof, and it is in conformity with our books, records and documents, and all reasonable efforts have been shown by our Company in order to obtain all information fully and accurately about the subject matter thereof, and we’re personally liable for the disclosures.